Conventional RT
Sponsors
Hospital Authority, Hong Kong, Dana-Farber Cancer Institute, Radiation Therapy Oncology Group, Centre Hospitalier Universitaire Vaudois
Conditions
AstrocytomaBasal Cell CarcinomaCarcinoma, Squamous CellCutaneous Squamous Cell CarcinomaGlioblastoma MultiformeGliomaLung CancerNSCLC
Phase 1
Phase 3
Unknown Phase
Benefit of Adding Chemotherapy And/Or Modification of Radiotherapy Schedule for Advance Nasopharyngeal Carcinoma (T3-4N0-1M0)
TerminatedNCT00563862
Start: 1999-07-31End: 2007-06-30Updated: 2011-06-16
Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0)
NCT00563927
Start: 1999-03-31End: 2009-10-31Target: 340Updated: 2010-07-07
FLASH Radiotherapy for Skin Cancer
Active, not recruitingNCT05724875
Start: 2023-06-22End: 2026-05-01Target: 60Updated: 2026-03-27